Wrapmanager Inc. Buys 69 Shares of Danaher Co. (NYSE:DHR)

Wrapmanager Inc. raised its stake in Danaher Co. (NYSE:DHR) by 4.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,728 shares of the conglomerate’s stock after purchasing an additional 69 shares during the quarter. Wrapmanager Inc.’s holdings in Danaher were worth $397,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC increased its holdings in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Trading Up 0.5 %

Shares of DHR opened at $211.23 on Tuesday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The firm has a market cap of $150.97 billion, a price-to-earnings ratio of 40.01, a PEG ratio of 2.66 and a beta of 0.83. The business’s fifty day moving average is $226.25 and its 200-day moving average is $246.44.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the company posted $2.09 EPS. Equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is presently 24.24%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Finally, The Goldman Sachs Group set a $250.00 price objective on Danaher in a report on Wednesday, January 15th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.